[If you do use the blog for research, practice submission or database purposes, citation would be appreciated, to the blog as a whole and /or to specific blog posts. Many have suggested I should turn the blog into a paid for, subscription service however I have resisted doing so. Proper reference to how the blog is useful to its readers, will help keeping this so.]
Cathay Biotech Inc v Wegochem Europe BV ECLI:NL:RBAMS:2025:3091 is a judgment of relevance to the meaning of ‘arising from’, used frequently in Rome II, Regulation 864/2007; as well as a salutary lesson in how not to apply Article 4 Rome II.
First, on the issue of ‘arising from’ in Article 8.
An alternative to ‘arising from’ used in Rome II is ‘arising out’, for instance in Article 7’s environmental claims: see e.g. Begum v Maran and see my paper on A7 here.
In China, patent infringement judgments have been issued regarding the production of nylon. PRC infringement continues by other entities that have also been held to account by Chinese courts. In current proceedings the patent holder sues a Dutch buyer of the nylon for unlawful conduct, arguing it knew or consciously accepted the significant risk that it was trading in infringing products.
In determining applicable law under Rome II, Cathay Biotech argue A4 is engaged; Wego Europe suggests A8(1) applies:
Article 8
Infringement of intellectual property rights
1. The law applicable to a non-contractual obligation arising from an infringement of an intellectual property right shall be the law of the country for which protection is claimed.
2. In the case of a non-contractual obligation arising from an infringement of a unitary Community intellectual property right, the law applicable shall, for any question that is not governed by the relevant Community instrument, be the law of the country in which the act of infringement was committed.
3. The law applicable under this Article may not be derogated from by an agreement pursuant to Article 14.
The court sides with Cathay Biotech: [5.6]:
The court agrees with Cathay Biotech that it bases its claim on unlawful conduct by Wego Europe… Although this alleged unlawful conduct by Wego Europe originates from the theft of trade secrets by third parties and (subsequent) patent infringements committed by third parties, this does not mean that there is an obligation between Wego Europe and Cathay Biotech ‘arising from’ an infringement of an intellectual property right as referred to in [A8(1) Rome II]. After all, the focus is on the unlawful conduct of Wego Europe described above, not on the question of whether Wego Europe (itself) infringes Cathay Biotech’s Chinese patents. The invocation of a patent right is therefore not the core of the dispute. The scope of the Rome II Regulation and Article 8 means that the aforementioned article only concerns claims relating to a non-contractual infringement of these (intellectual property) rights.
I disagree. Cathay’s claim as it is summarised in 4.4 walk and talks intellectual property rights infringement:
Cathay Biotech bases its claim, in summary, on the following. Wego Europe acts unlawfully towards Cathay Biotech by importing and distributing [long chain dicarboxylic acid] LCDA from the Facility in Europe, while knowing that the production of these LCDA by Hilead and the Users infringes Cathay Biotech’s Chinese patents and that many Chinese court rulings in this regard are being systematically ignored. Wego Europe facilitates the unlawful actions of Hilead and the Users by creating a market for these parties and knowingly profits from their unlawful conduct.
Patent infringement is not a context for Cathay’s claim against Wego: it is its roots and branch. The statutory construction of both ‘arising from’ and ‘out’ (similarly, see Lliuya v RWE where no time was wasted at all on whether climate claims ‘arise out’ of environmental damage) instruct a causal link at the lower level of causal intensity. Cathay’s claim and its formulation approaches that of conspiracy to cause or at the very least purposedly profit from patent infringement. That in my view must fall within Article 8.
Once Article 8 so dismissed, the court then goes off the rails in its Article 4 locus damni analysis. [5.7 and 5.8]
- it links A4 Rome II squarely to A7(2) Brussels Ia, recalling that Article’s split between Handlungsort and Erfolgort.
- It then squarely suggests that within the A4 Rome II analysis, claimant may chose either Handlugsort or Erfolgort as determining the applicable law (plainly wrong);
- it identifies each distribution center within the EU as a Handlungsort. This is as such an interesting proposition, echoing my suggestions for competition law; yet it is completely out off place in the A4 Rome II analysis.
- it considers Chinese law as applicable law under the Handlungsort analysis (although this would require Cathay’s economic loss (its consolidated accounts are in China) to be considered as ‘direct’ damages per A4, instead of eg the place of the loss of market share in the EU Member States as places of direct damage);
- it finally ends up [5.10] in Dutch law as applying to the claim as a whole under A4(3)’s escape clause, in essence because The Netherlands is held to be the locus delicti commissi: Wego is held to have organised its nylon distribution entirely from The Netherlands.
The judgment amounts to very poor engagement with Rome II.
Geert.
EU Private International Law, 4th ed. 2024. Chapter 4.